
HTTP/1.1 200 OK
Date: Sat, 11 Feb 2012 02:19:20 GMT
Server: Apache/1.3.26 (Unix) DAV/1.0.3 ApacheJServ/1.1.2
Window-Target: _top
X-Highwire-SessionId: eo3lshjb62.JS1
X-Highwire-SessionId: eo3lshjb62.JS1
Connection: close
Content-Type: text/html

Arch Neurol -- Top 50 Cited Articles You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better. Select Journal or Resource -------------------------- JAMA & Archives Home JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Neurology and Psychiatry (1919-1959) Ophthalmology Otolaryngology—Head & Neck Surgery Pediatrics & Adolescent Medicine Surgery JAMA & Archives CME Calendar of Events JAMA Career Center For The Media JAMAevidence AMA Manual of Style Peer Review Congress JAMA-français ABOUT ARCHIVES Search: Advanced Search Institution: Carnegie Mellon University  | My Account | E-mail Alerts | RSS


 | Access Rights | Sign In Home Current Issue Past Issues Topic Collections CME Physician Jobs Submit Subscribe Help Information for: Authors/Reviewers Readers Institutions/Libraries Subscription Agents News Media Job Seekers/Employers Advertisers Fifty Most-Cited Archives of Neurology Articles Published January 1, 2008, through December 31, 2010 Times cited are as of May 2011. Li H, Wetten S, Li L, et al. Candidate single-nucleotide polymorphisms from a genomewide 

association study of Alzheimer disease . Arch Neurol . 2008;65(1):45-53. Times cited: 133. Letendre S, Marquie-Beck J, Capparelli E, et al. Validation of the CNS 

penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system . Arch Neurol . 2008;65(1):65-70. Times cited: 122. Aizenstein HJ, Nebes RD, Saxton JA, et al. Frequent amyloid deposition without significant 

cognitive impairment among the elderly . Arch Neurol . 2008;65(11):1509-1517. Times cited: 91. Fleisher AS, Raman R, Siemers ER, et al. Phase 2 safety trial targeting amyloid β 

production with a γ-secretase inhibitor in Alzheimer disease . Arch Neurol . 2008;65(8):1031-1038. Times cited: 71. Lee VH, Wijdicks EFM, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior 

leukoencephalopathy syndrome . Arch Neurol . 2008;65(2):205-210. Times cited: 70. Pittock SJ, Lennon VA, de Seze J, et al. Neuromyelitis optica and non–organ-specific 

autoimmunity . Arch Neurol . 2008;65(1):78-83. Times cited: 65. Soto C, Estrada LD. Protein misfolding and neurodegeneration . Arch Neurol . 

2008;65(2):184-189. Times cited: 58. Jacob A, Weinshenker BG, Violich I, et al. Treatment of neuromyelitis optica with 

rituximab retrospective analysis of 25 patients . Arch Neurol . 2008;65(11):1443-1448. Times cited: 56. Martin BK, Szekely C, Brandt J, et al. Cognitive function over time in the Alzheimer’s 

Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib . Arch Neurol . 

2008;65(7):896-905. Times cited: 55. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and 

longitudinally extensive transverse myelitis . Arch Neurol . 2008;65(7):913-919. Times cited: 51. Tapiola T, Alafuzoff I, Herukka SK, et al. Cerebrospinal fluid β-amyloid 42 and tau 

proteins as biomarkers of Alzheimer-type pathologic changes in the brain . Arch Neurol . 2009;66(3):382-389. Times cited: 50. Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and 

mild cognitive impairment . Arch Neurol . 2009;66(2):216-225. Times cited: 48. Geser F, Brandmeir NJ, Kwong LK, et al. Evidence of multisystem disorder in whole-brain map 

of pathological TDP-43 in amyotrophic lateral sclerosis . Arch Neurol . 2008;65(5):636-641. Times cited: 47. Helzner EP, Luchsinger JA, Scarmeas N, et al. Contribution of vascular risk factors to the 

progression in Alzheimer disease . Arch Neurol . 2009;66(3):343-348. Times cited: 45. Byun E, Caillier SJ, Montalban X, et al. Genome-wide pharmacogenomic analysis of the 

response to interferon beta therapy in multiple sclerosis . Arch Neurol . 2008;65(3):337-344. Times cited: 45. Welter ML, Mallet L, Houeto JL, et al. Internal pallidal and thalamic stimulation in 

patients with Tourette syndrome . Arch Neurol . 2008;65(7):952-957. Times cited: 44. Palop JJ, Mucke L. Epilepsy and cognitive impairments in Alzheimer disease . Arch 

Neurol . 2009;66(4):435-440. Times cited: 42. Morris JC, Roe CM, Grant EA, et al. Pittsburgh compound B imaging and prediction of 

progression from cognitive normality to symptomatic Alzheimer disease . Arch Neurol . 2009;66(12):1469-1475. Times cited: 41. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two 

roads converged . Arch Neurol . 2009;66(3):300-305. Times cited: 40. Irie F, Fitzpatrick AL, Lopez OL, et al. Enhanced risk for Alzheimer disease in persons with 

type 2 diabetes and APOE ε4 . Arch Neurol . 2008;65(1):89-93. Times cited: 40. Mata IF, Samii A, Schneer SH, et al. Glucocerebrosidase gene mutations: a risk factor for 

Lewy body disorders . Arch Neurol . 2008;65(3):379-382. Times cited: 39. Schwarzschild MA, Schwid SR, Marek K, et al. Serum urate as a predictor of clinical and 

radiographic progression in Parkinson disease . Arch Neurol . 2008;65(6):716-723. Times cited: 38. Kassis I, Grigoriadis N, Gowda-Kurkalli B, et al. Neuroprotection and immunomodulation with 

mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis . Arch Neurol . 2008;65(6):753-761. Times cited: 38. Middleton LE, Yaffe K. Promising strategies for the prevention of dementia . Arch 

Neurol . 2009;66(10):1210-1215. Times cited: 37. Brodsky M, Nazarian S, Orengo-Nania S, et al. Multiple sclerosis risk after optic neuritis: 

final Optic Neuritis Treatment Trial follow-up . Arch Neurol . 2008;65(6):727-732. Times cited: 37. Leinonen V, Alafuzoff I, Aalto S, et al. Assessment of β-amyloid in a frontal 

cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh compound B . Arch Neurol . 

2008;65(10):1304-1309. Times cited: 36. Sundelof J, Giedraitis V, Irizarry MC, et al. Plasma β amyloid and the risk of 

Alzheimer disease and dementia in elderly men . Arch Neurol . 2008;65(2):256-263. Times cited: 36. Geser F, Martinez-Lage M, Robinson J, et al. Clinical and pathological continuum of 

multisystem TDP-43 proteinopathies . Arch Neurol . 2009;66(2):180-189. Times cited: 35. Nowak DA, Grefkes C, Dafotakis M, et al. Effects of low-frequency repetitive transcranial 

magnetic stimulation of the contralesional primary motor cortex on movement kinematics and neural activity in subcortical stroke . Arch Neurol . 

2008;65(6):741-747. Times cited: 34. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years 

later . Arch Neurol . 2009;66(12):1447-1455. Times cited: 33. Boeve BF, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 

17: introducing FTDP-17 ( MAPT ) and FTDP-17 ( PGRN ) . Arch Neurol . 2008;65(4):460-464. Times cited: 33. Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL. Brain volume decline in aging . Arch Neurol . 2008;65(1):113-120. Times cited: 33. Steinacker P, Hendrich C, Sperfeld AD, et al. TDP-43 in cerebrospinal fluid of patients 

with frontotemporal lobar degeneration and amyotrophic lateral sclerosis . Arch Neurol . 2008;65(11):1481-1487. Times cited: 32. Roberts RO, Geda YE, Knopman DS, et al. Association of duration and severity of diabetes 

mellitus with mild cognitive impairment . Arch Neurol . 2008;65(8):1066-1073. Times cited: 32. Axelrad JE, Louis ED, Honig LS, et al. Reduced Purkinje cell number in essential tremor . Arch Neurol . 2008;65(1):101-107. Times cited: 32. Waring SC, Rosenberg RN. Genome-wide association studies in Alzheimer disease . Arch 

Neurol . 2008;65(3):329-334. Times cited: 31. Pandolfo M. Friedreich ataxia . Arch Neurol . 2008;65(10):1296-1303. Times cited: 30. DelleDonne A, Klos KJ, Fujishiro H, et al. Incidental Lewy body disease and preclinical 

Parkinson disease . Arch Neurol . 2008;65(8):1074-1080. Times cited: 30. Bielekova B, Howard T, Packer AN, et al. Effect of anti-CD25 antibody daclizumab in the 

inhibition of inflammation and stabilization of disease progression in multiple sclerosis . Arch Neurol . 2009;66(4):483-489. Times cited: 29. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of 

dementia: Cardiovascular Health Study . Arch Neurol . 2009;66(3):336-342. Times cited: 29. Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E. The spectrum of 

parkinsonian manifestations associated with glucocerebrosidase mutations . Arch Neurol . 2008;65(10):1353-1357. Times cited: 28. Seeley WW, Crawford R, Rascovsky K, et al. Frontal paralimbic network atrophy in very mild 

behavioral variant frontotemporal dementia . Arch Neurol . 2008;65(2):249-255. Times cited: 28. Spence JD, Coates V, Li H, et al. Effects of intensive medical therapy on microemboli and 

cardiovascular risk in asymptomatic carotid stenosis . Arch Neurol . 2010;67(2):180-186. Times cited: 27. Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with 

cognitive impairment in relapsing-remitting multiple sclerosis . Arch Neurol . 2009;66(9):1144-1150. Times cited: 27. Yaffe K, Weston AL, Blackwell T, Krueger KA. The metabolic syndrome and development of 

cognitive impairment among older women . Arch Neurol . 2009;66(3):324-328. Times cited: 27. Zaveri MS, Conger A, Salter A, et al. Retinal imaging by laser polarimetry and optical 

coherence tomography evidence of axonal degeneration in multiple sclerosis . Arch Neurol . 2008;65(7):924-928. Times cited: 27. Pettersen JA, Sathiyamoorthy G, Gao FQ, et al. Microbleed topography, leukoaraiosis, and 

cognition in probable Alzheimer disease from the Sunnybrook Dementia Study . Arch Neurol . 2008;65(6):790-795. Times cited: 27. Cattaneo L, Rizzolatti G. The mirror neuron system . Arch Neurol . 

2009;66(5):557-560. Times cited: 26. Smith EE, Egorova S, Blacker D, et al. Magnetic resonance imaging white matter 

hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia . Arch Neurol . 2008;65(1):94-100. Times cited: 26. Sonnen JA, Larson EB, Brickell K, et al. Different patterns of cerebral injury in dementia 

with or without diabetes . Arch Neurol . 2009;66(3):315-322. Times cited: 25. HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MA